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INTRODUCTION
As of 2018, 39 cases of face transplantation have been per-
formed [1]. The ethical and immunosuppressant-related issues 
that were brought up in the early period of vascularized com-
posite tissue allotransplantation (VCA) have been addressed. 
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erage time intervals between the first brain death decision and medical confirmation using 
electroencephalography and between the first brain death decision and the final determina-
tion of brain death were 16 hours 58 minutes (±14 hours 50 minutes) and 22 hours 57 min-
utes (±16 hours 16 minutes), respectively. The most common cause of brain death was cere-
bral hemorrhage/stroke (42.3%), followed by hypoxia (30.1%), and head trauma (25.2%).
Conclusions When face transplantation is performed, the transplantation team has 22 hours 
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The results for facial expression capacity and control of rejection 
have so far been satisfactory [2]. 
However, facial transplantation is not widely performed be-
cause the number of possible recipients is not as high as that of 
possible vital organ recipients. Moreover, differences exist from 
country to country in terms of regulations, systems, legal issues, 
associations, and cultural and social consensus [3-6]. Neverthe-
less, sufficient common ground exists for facial transplantation 
to be incorporated into the current organ transplantation system.
When a donor for solid organ transplantation becomes brain-
dead, patient information including medical history, a broad 
range of immunological testing, and clinical and imaging studies 
must be confirmed and shared with the recipient hospital. Un-
like in cases of solid organ transplantation, the condition of the 
skin, soft tissue, and bone must be evaluated for facial or hand 
transplantations. Since the nerves and vascular structures are su-
perficial, unlike internal organs, a previous history of trauma or 
surgical incisions is important and must be noted. In addition, 
skin color and tone differs by age, sex, race, and individual varia-
tions [7]. Therefore, in cases of face transplantations, the plastic 
surgery team must directly interact with the brain-dead patient 
and perform clinical and physical evaluations that are more de-
tailed than those needed for the conventional solid organ trans-
plantation information-sharing system. Additionally, a donor fa-
cial restoration in the form of a mask should be prepared before 
the end of donor procurement. Considering all these steps, 
there is often not enough time before performing facial trans-
plantations.
We investigated the timing of brain-dead donor processing 
and factors influencing that process. We also aimed to deter-
mine how much time is available to prepare for facial transplan-
tations. To that end, we analyzed the actual time taken in the 
process from the occurrence of potential brain death events to 
the final brain death decision. 
METHODS
Organ transplantation organization and the brain death 
decision-making process
Organ transplantation is regulated by the Organ Transplantation 
Act in Korea. The Korean Network for Organ Sharing (KO-
NOS), which is under the supervision of the Ministry of Health 
and Welfare, manages the organ transplantation process. The 
enrollment of potential brain-dead patients and the process of 
matching them to recipient patients is well-regulated by govern-
ment organizations. When a suspected case of brain death oc-
curs, the hospital reports the case to KONOS after the family 
agrees to organ donation. Next, the potential brain-dead patient 
goes through the brain death confirmation process before organ 
transfer to waiting recipient patients who are also confirmed by 
KONOS [8]. We submitted the plan for the present study to 
KONOS and requested data. Prior to sending the data, KONOS 
excluded personal information. After officially being given the 
de-identified data, we conducted the analysis described herein. 
The final brain death decision must be made before organ pro-
curement. For each donor, the first and second brain death deci-
sions are made at each hospital on the basis of physical examina-
tions. According to the Organ Transplantation Act, the second 
brain death decision is made at least 6 hours after the first brain 
death decision for patients above 6 years of age. Then, electro-
encephalography (EEG) is performed to ensure that the final 
brain death decision meets medical criteria for brain death. The 
final brain death decision is made by a specific committee with 
the task of performing a comprehensive examination to ascer-
tain brain death. The actual surgical procedure for organ pro-
curement is performed after the final confirmation of brain 
death (Fig. 1) [9-11].
Study design
We analyzed 1,074 brain-dead donors from January 2015 to 
December 2016 in Korea. All patients were enrolled in the or-
gan transplantation program. All of the data were officially re-
ceived from KONOS. However, the analyzed factors differed 
from those in the KONOS annual report. Since the fundamen-
tal purpose of this study was to investigate the process that 
would be utilized for face transplantations in adults, we targeted 
adults at least 19 years of age who were not considered minors 
under Korean law, yielding a total of 1,004 brain-death donors. 
We analyzed the time intervals of the clinically relevant points 
from admission to the final brain death decision. We also ana-
lyzed patients’ age, blood type, and reasons for brain death. 
We investigated each time interval involving the first brain 
death decision, the second brain death decision, the EEG deci-
sion, and the final brain death decision. Time was analyzed from 
admission for the medical event that caused brain death. Since 
donor information is officially shared after the first brain death 
decision, we regarded the first brain death decision as an impor-
tant milestone. The second brain death decision can be made at 
least 6 hours after the first brain death decision by law. Since the 
brain death decision process and preparation for the procure-
ment operation are performed quickly after the second brain 
death decision, the second brain death decision is also an im-
portant time point. The EEG decision and final decision by the 
committee for determining brain death play a meaningful role in 
terms of medical and social confirmation of brain death. The fi-
nal brain death decision is made by a committee composed of 
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medical staff, lawyers, hospital staff, clergy, and socially well-
known people, taking social consensus and ethical consider-
ations into account.
Statistical analysis
Continuous variables are summarized as mean values ( ± stan-
dard deviation). Data analyses were performed using SPSS ver-
sion 13.0 (SPSS Inc., Chicago, IL, USA). 
RESULTS
We analyzed all patients (n = 1,074) by age. The greatest num-
ber of females and males were in their 40s and 50s, respectively. 
The majority of brain-dead donors were in their 50s, and males 
were 2.3 times as common as females. The number of donors in 
their 40s and 50s accounted for 53.6% of all the donors (Fig. 2). 
Organ-specific transplantations with an ABO blood type mis-
Fig. 1. The brain death decision process in Korea
Two brain death decisions are made on the basis of physical examinations. Electroencephalography (EEG) is performed to confirm brain death. 
The final brain death decision is rendered by the committee for determining brain death at each hospital. Donations for transplantations can then 
be performed. The entire procedure is performed under the Organ Transplantation Act.
Admission
First brain death decision
Second brain death decision
EEG brain death decision
(Final brain death decision)
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Fig 2. Age distribution of brain death donors
Overall, there were 2.3 times more male donors than female donors. 
The most common age for brain death was 51–60 years for males 
and 41–50 years for females. Those age groups accounted for 
53.6% of all brain death donors. 
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Fig. 3. ABO blood type distribution among brain-dead donors
The AB type accounted for the smallest proportion of donors, at 
12%. The distribution of blood types in this study is similar to that 
of the Korean general population. 
350
300
250
200
150
100
50
0
N
o.
 o
f 
pa
tie
nt
s 
A B AB O
ABO type
328
(32%) 
284
(26%) 
119
(12%) 
273
(30%) 
Hong JW et al. Process of face transplantation
408
match can be performed, but for face transplantations, the ABO 
blood type should be matched to reduce the possibility of rejec-
tion. Blood type analysis was performed for donors who were at 
least 19 years of age and considered legal adults. The AB type 
was present in 12% of the donors, while the A, B, and O blood 
types made up 32%, 26%, and 30% of the patient population in 
this study, respectively. This distribution was similar to the 
blood type distribution of the Korean general population (Fig. 
3) [12].
The time interval between each point in the brain death pro-
cess is shown in Table 1. An average of 6.6 days passed from ad-
mission to the first brain death decision. Not all patients become 
brain-dead immediately after admission. In addition, the fami-
lies of potentially brain-dead patients did not always agree to or-
gan donation immediately. Therefore, the timeframe from ad-
mission to the first brain death decision was relatively long. The 
longest time interval from admission to the first brain death de-
cision was 30 days. The second brain death decision can be 
made starting 6 hours after the first brain death decision under 
the Organ Transplantation Act. However, the average time in-
terval was 11 hours and 2 minutes. The average time from the 
second brain death decision to EEG confirmation was 6 hours, 
even though EEG is part of the confirmation process. That 
means that EEGs were not performed urgently. The time from 
Brain death decision process Time interval (mean±SD) Range
Admission to first brain death decision 6.6±5.5 day 0–30 day
First to second brain death decision 11 hr 2 min±6 hr 48 min 6 hr 5 min–3 day 19 hr 35 min
Second brain death decision to EEG 6 hr±11 hr 50 min 30 min–6 day 1 hr 50 min
EEG to final brain death decision 6 hr 2 min±8 hr 9 min 5 min–2 day 23 hr
First brain death decision to EEG 16 hr 3 min±13 hr 35 min 6 hr 35 min–6 day 9 hr 45 min
First to final brain death decision 22 hr 2 min±15 hr 11 min 6 hr 49 min–6 day 12 hr 35 min
Second to final brain death decision 10 hr 59 min±13 hr 58 min 39 min–6 day 4 hr 40 min
EEG, electroencephalography.
Table 1. Analysis of the timing of the process from admission to the final brain death decision
Fig. 4. Time intervals until EEG brain death
The electroencephalography (EEG) decision represents the medical determination of brain death. The first brain death decision is important for 
practical surgical preparation. The time from admission to the first brain death decision took an average of 6.6 days. The time from the first brain 
death decision to the EEG decision took an average of 16 hours and 3 minutes. 
Admission
First brain death decision
Second brain death decision
EEG brain death decision
(Final brain death decision)
Committee
Donation
6.6 day
6 hr11 hr 2 min
16 hr 3 min
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Cause No.
Proportion of cases 
of brain death due to 
hypoxia (n=286)
Proportion of all 
cases of brain death 
(n=1,004)
Asphyxia 155 54.2 15.4
Cardiac arrest 92 32.2 9.2
Drowning  6 2.1 0.6
Seizure  5 1.7 0.5
Other  28 9.8 2.8
Total 286 100.0 28.5
Values are presented as percent.
Table 2. Causes of hypoxic brain death
Fig. 5. Time intervals until final brain death
The time from the electroencephalography (EEG) decision to the committee decision was, on average, 6 hours and 2 minutes, while an average of 
22 hours and 2 minutes was needed from the first brain death decision to the committee decision. 
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Fig. 6. Causes of brain death 
The most common cause of brain death was cerebrovascular dis-
ease/stroke. The second and third most common causes were brain 
hypoxia and head trauma, respectively.
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the EEG brain death confirmation to committee confirmation 
took an average of 6 hours and 2 minutes, even though brain 
death had already been confirmed medically.
It took an average of 16 hours and 3 minutes from the first 
brain death decision to the EEG for the medical confirmation of 
brain death. However, actual organ transplantation is only possi-
ble after the decision of the committee. Therefore, when ana-
lyzed based on the decision of the committee for determining 
brain death decision, an average of 22 hours and 2 minutes 
passed from the first brain death decision to EEG confirmation. 
An average of 10 hours and 59 minutes elapsed from the second 
brain death decision to the final brain death decision (Figs. 4, 5).
Unlike solid organ transplantations, knowledge of a previous 
surgical or trauma history to the face is very important in VCA, 
especially for cases of brain death due to head trauma, in which 
facial trauma is likely to occur. As all head trauma patients expe-
rience facial trauma, we thought that it would be meaningful to 
Hong JW et al. Process of face transplantation
410
analyze the reason for brain death to allow for an indirect esti-
mate of the cases in which facial trauma would be likely. The 
most common reason for brain death was cerebrovascular dis-
ease/stroke, which accounted for 44.4% of brain deaths; mean-
while, 28.5% were attributed to brain hypoxia and 25.2% to 
head trauma (Fig. 6).
Unlike other causes of brain death, brain hypoxia is a category 
that contains many previous diagnoses. We analyzed 286 hy-
poxic brain deaths, and most resulted from asphyxia (54.2%). 
The second leading cause of hypoxic brain death was cardiac ar-
rest (32.2%) (Table 2). Fifty-three cases of hypoxic brain death 
resulted from suicide by hanging.
DISCUSSION
Organ transplants are emergent procedures, as distinct from 
elective surgery. The recipient must be ready to enter the hospi-
tal at any time since it is impossible to predict when a donor will 
appear. If a surgeon has a donor, the surgeon must be able to 
perform the relevant surgery at a moment’s notice. Previously 
performed face transplantation procedures have taken much 
longer than conventional reconstructive procedures [13]. Do-
nor-recipient suitability must be determined according to fac-
tors that are never considered for traditional transplants, such as 
soft tissue condition, skin color, skin tone, hair, and age, in addi-
tion to immunological factors. This information must be veri-
fied directly by the operators themselves.
Due to these novel requirements for information, it takes a 
long time to prepare the donor before surgery. Knowing how 
much time is required before any transplantation operation can 
be helpful not only for preoperative preparations, but also for 
management of the transplantation team, with goals including 
efficient allocation of time and maintenance of stamina. 
VCA has steadily become more common worldwide, with in-
creases observed in the number of surgical procedures, opera-
tive fields, nations, and durations from the first modern hand 
transplantation in Lyon, France in 1998 [14]. Hand transplanta-
tions have been performed in more than 80 cases, while facial 
transplantations have been performed in 39 cases [1,14]. Most 
of the cases were performed in the United States and Europe, 
but some have been performed in other nations, such as Turkey 
and Taiwan [14-16]. The results of VCA, especially for face and 
hand transplantations, are very inspiring so far, with great im-
provements observed in patients’ lives. The immunosuppres-
sant drugs that were once major issues at the beginning of VCA 
have become more similar to the regimens used for solid organ 
transplantation. In addition, studies have been conducted to 
identify ways to induce immune tolerance in clinical settings 
[17]. In Korea, the first upper limb transplantation procedure 
was performed in February 2017. Hand function and immuno-
suppression have been well maintained in that patient 2 years. 
As a result, the Organ Transplantation Act was revised in 2017, 
with Korea moving towards institutional improvements and a 
greater social consensus [18,19].
However, there are many issues that remain to be solved in or-
der to perform VCA. Even if a procedure is possible on the 
medical level, numerous institutional, social, and ethical issues 
must be resolved in conjunction with other medical fields [20-
22]. Therefore, it is rational to incorporate VCA into the current 
transplantation system. This has been a common approach to 
VCA at other medical institutions internationally. However, 
plastic surgeons are not generally familiar with the transplanta-
tion system, and solid organ transplantation surgeons are not 
usually familiar with the reconstructive field. Plastic surgeons 
have little knowledge of organ procurement and transplantation 
procedures in brain-dead donors. The entire management of 
the process from its preoperative stages (including recipient and 
donor selection) to its postoperative stages (including immune 
suppression) is very important to the success of VCA [23,24].
All nations manage donors and recipients fairly and ethically 
in a way that is deeply grounded in ethical principles through 
organizations such as KONOS in Korea, the United Network 
for Organ Sharing in the United States, and the Japan Organ 
Transplant Network in Japan. In those organizations, informa-
tion on brain-dead donors is shared with the recipient medical 
team. Face transplantations are uncommon in the organ trans-
plantation field. The shared information about the donor must 
contain information about the face, including facial movements, 
soft tissue conditions, skin color, and hair, in addition to the im-
munological information that is already shared. Therefore, it is 
difficult to rely on traditional brain-dead donor organizations 
that are not used to facial transplantations. The reconstructive 
transplantation team that will perform the face transplantation 
must directly check and evaluate the brain death donor patient. 
A facial mask for the donor patient must also be prepared for fa-
cial restoration for their funeral before the end of the donor pro-
curement operation. These processes are very different from 
solid organ transplantations, which only require shared informa-
tion about solid organs.
The actual time interval from the preparation of the brain-
dead patient to the actual start of the face transplantation sur-
gery must be known. To predict how many brain-dead donors 
can be candidates for face transplantation donation, we analyzed 
their age, blood type, and causes of brain death, which are basic 
data that differ from country to country. The purpose of this 
study was to investigate the time interval from the identification 
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of a potential brain-dead donor to brain death confirmation 
with reference to Korean demographics. 
We investigated 2 years of data from KONOS, from January 
2015 to December 2016. Age and sex are meaningful for face 
transplantations because skin color, tone, and character usually 
differ according to age and sex. Recently, ABO blood mismatch 
organ transplantations have become available for several condi-
tions. Nonetheless, it remains the case that every antigen should 
be matched in order to prevent rejection in VCA, based on its 
short history. Since the ABO blood type must be matched for 
face transplantations, we analyzed the blood types of the brain-
dead donors. The distribution of the ABO blood types of the 
patients in this study is similar to the distribution in the Korean 
general population.
We consider the first brain death decision to be a very impor-
tant time point, as it is when information about the brain-dead 
donor begins to be shared. EEG decisions and committee deci-
sions were also considered to be important time points for final 
medical brain death decisions and comprehensive decisions. 
Clinically, preparations for organ transplantations begin after 
the first brain death decision. The recipient is hospitalized and 
prepared for surgery. The next step after the second brain death 
decision involves the confirmation process. Therefore, the sec-
ond brain death decision is also a meaningful time point. 
In the time interval analysis, standard deviation and range 
were quite wide in each category. Therefore, it was not meaning-
ful to compare each group using the t-test. Since vascular events 
in the central nervous system are commonly caused by stroke or 
hemorrhage, head trauma, cardiovascular ischemia, and sudden 
heart attacks, patients’ conditions may be unstable and variable. 
In addition, organ donations are difficult decisions for families 
and medical staff because of extra-medical issues. These reasons 
explain the wide range of the data. Admissions of possible brain-
dead donors are challenging to standardize. As a result, the time 
interval from admission to the first brain death decision varied 
considerably. 
Summarizing various results and their causes, we believe that 
the interval from the first brain death decision to the EEG deci-
sion about medical brain death is the ideal time for preoperative 
preparations to check the condition of the donor face and to de-
cide whether face transplantation is possible. Since face trans-
plantations can begin after the decision of the committee, the 
time from the first brain death decision to the final brain death 
decision by the committee is a bonus in terms of preparation for 
surgery. These intervals were, on average, 16 hours and 3 min-
utes and 22 hours and 2 minutes, respectively. The standard de-
viation and range must be taken into account, as various factors 
may cause an increase or reduction in the actual time compared 
to the average time. 
Since the majority of brain deaths are due to traffic accidents, 
we analyzed the causes of brain death involving the possibility 
of facial trauma. Head trauma accounted for 28.5% of brain 
deaths. Although head trauma does not perfectly coincide with 
facial trauma, it is possible to use head trauma statistics as a 
rough estimate of the number of patients from whom this possi-
bility must be considered. Furthermore, 44.4% and 25.2% of 
donor brain deaths resulted from cerebrovascular disease/stroke 
and brain hypoxia, respectively. Hypoxia was very common in 
the data from KONOS. Therefore, the mechanism of death in 
the hypoxia cases was analyzed. Hypoxia due to cardiac arrest 
was found in 92 (15.4%) of the 1,004 total brain deaths. How-
ever, the number of suicides was 53 in this study. This result did 
not include suicides by carbon monoxide poisoning or drown-
ing. In the future, it is necessary to discuss whether donors who 
have committed suicide can be used for face transplantations.
We previously analyzed the time interval of the brain death 
decision process for 648 brain death donors between January 
2011 to August 2012. In that time period, the time from the first 
brain death decision to the EEG decision was, on average, 14 
hours and 35 minutes, while the interval from the first brain 
death decision to the decision of the committee took an average 
of 18 hours and 11 minutes. In a recent study, the time intervals 
had increased [25], but no meaningful difference was seen be-
cause there was at least a 4-year gap between the two study 
groups. The standard deviations were also too large for the dif-
ference to be statistically significant. In a previous study, the or-
gans used for transplantations were analyzed. Hearts and/or 
lungs were procured in 30.1% of donors from January 2011 to 
August 2012. The possibility of interference between face trans-
plantation and heart and lung transplantation teams must be 
discussed. 
It is not straightforward for the new area of VCA to join the 
existing traditional solid organ transplantation field. Each field 
must have an understanding of the other. In the first upper limb 
transplantation performed in Korea in February 2017, the organ 
procurement procedure took only 15 minutes, but there were 
many issues related to donor procurement. More factors must 
be taken into account for face transplantations than for hand 
transplantations. Face transplantations were rejected three times 
by the Korean government from 2010 to 2017 as a new technol-
ogy for insurance coverage in Korea. Fortunately, existing organ 
transplantation specialists and institutions have become familiar 
with the procedure and have tried to develop VCA through the 
revised Organ Transplantation Act. There are fewer candidates 
for face transplantations in Korea than in other countries where 
the procedure has already been performed. In addition, the so-
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ciocultural background of organ donation is different across 
countries. Nonetheless, considering the medical outlook in Ko-
rea and the reconstructive level of plastic surgery, the possibility 
of face transplantation should be considered when the opportu-
nity arises. 
Plastic surgeons must understand the overall transplantation 
process. Specific factors must be investigated for face transplan-
tations, in addition to those which are routinely conducted for 
other transplantation fields. Based on this study and previous 
research, plastic surgeons should continue to improve their 
knowledge of transplantation procedures, increase their level of 
collaboration with transplantation specialists, and make sugges-
tions based on evidence and opinions for the revision of institu-
tional and legal policies. 
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